Department of Immunology & Microbial Disease

Immunology and Microbial Disease at Albany Med
Emphasizing research on infectious disease, pathogenesis, and protection.
immunology static header

Admissions Application

Please submit application

by December 31, 2015 to

receive full consideration by

the Admissions Committee.

The Department of Immunology & Microbial Disease has an emphasis on infectious disease pathogenesis and protection. The emergence of new pathogens, the increasing development of drug resistance and the threat of bioterrorism have combined to create an increased demand for investigations into the mechanisms of disease and the body's ability to combat these diseases. Specialized areas within the Department of Immunology & Microbial Disease include immunology, microbial and viral pathogenesis, and molecular mechanisms responsible for human disease.

Of particular note is the collaborative nature of the Research and Training Program within the Department of Immunology and Microbial Disease. Our Program brings together a diverse group of investigators, including 20 faculty members and numerous predoctoral and postdoctoral trainees, with particular expertise in the fields of microbiology, cell biology, and immunology. The research and training effort, currently supported by over $30M in federal funding, concentrates on exploring, in an integrated fashion, host-pathogen interactions during infections with various microbes, including influenza virus, Category A biothreats such as Francisella tularensis and Yersinia pestis, HIV-1, Lyme disease, MRSA, and pneumococcal infections.

The Program is supported by a state-of-the-art Biosafety Level 3 laboratory and animal facility that allows the use of highly virulent human pathogens in mice and is one of only a few such facilities in the Capital Region. The Program also includes Core Immunology and Microbiology Laboratories that provide modern instrumentation and technical support for cell analysis and sorting, confocal microscopy, immunohistology, and immune cytokine quantitation. The results of our studies will ultimately be used to evaluate new vaccination strategies and vaccine candidates against human microbial pathogens.

CIMD 2015 Retreat 

2015 Annual Research Retreat